| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,064 |
8,124 |
$491K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,141 |
5,596 |
$488K |
| 99490 |
Ccm add 20min |
3,202 |
2,921 |
$99K |
| 99401 |
|
5,155 |
4,744 |
$95K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,050 |
1,031 |
$87K |
| 99497 |
|
1,164 |
1,134 |
$63K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,624 |
3,541 |
$53K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
376 |
370 |
$36K |
| 99215 |
Prolong outpt/office vis |
420 |
395 |
$34K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
889 |
818 |
$31K |
| 80305 |
|
2,986 |
2,844 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
156 |
155 |
$23K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
626 |
180 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
2,778 |
2,672 |
$16K |
| 93922 |
|
325 |
321 |
$14K |
| 99205 |
Prolong outpt/office vis |
70 |
69 |
$13K |
| 95923 |
|
193 |
189 |
$12K |
| 99072 |
|
718 |
613 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
574 |
202 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
232 |
64 |
$7K |
| 82962 |
|
3,795 |
3,237 |
$7K |
| 93923 |
|
59 |
58 |
$4K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
100 |
94 |
$3K |
| 99173 |
|
96 |
93 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,528 |
1,414 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
19 |
18 |
$2K |
| 99397 |
|
56 |
52 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
102 |
99 |
$2K |
| 99406 |
|
126 |
115 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,264 |
1,171 |
$2K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
95 |
93 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
230 |
200 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
759 |
700 |
$1K |
| 80306 |
|
94 |
90 |
$1K |
| 90688 |
|
103 |
102 |
$928.99 |
| 95943 |
|
28 |
27 |
$851.70 |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
86 |
81 |
$767.82 |
| 97014 |
|
70 |
26 |
$721.36 |
| 92551 |
|
41 |
41 |
$462.36 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
144 |
134 |
$390.58 |
| 81002 |
|
191 |
180 |
$337.69 |
| 99000 |
|
160 |
157 |
$324.49 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
12 |
12 |
$302.06 |
| 97035 |
|
35 |
12 |
$278.14 |
| 90656 |
|
17 |
17 |
$243.48 |
| 94760 |
|
160 |
148 |
$144.33 |
| 96116 |
|
16 |
14 |
$60.52 |
| 82270 |
|
19 |
18 |
$49.44 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
29 |
28 |
$49.08 |
| 3017F |
|
6,052 |
4,382 |
$21.75 |
| 4040F |
|
1,468 |
1,222 |
$3.24 |
| G8484 |
Influenza immunization was not administered, reason not given |
614 |
523 |
$2.40 |
| M1189 |
Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed |
1,633 |
1,389 |
$0.01 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,878 |
2,452 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
1,104 |
1,012 |
$0.00 |
| 3046F |
|
464 |
400 |
$0.00 |
| G8399 |
Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed |
733 |
582 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
2,358 |
2,017 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
7,687 |
6,492 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
829 |
687 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
589 |
490 |
$0.00 |
| G9991 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
77 |
71 |
$0.00 |
| 4005F |
|
77 |
76 |
$0.00 |
| M1190 |
Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) |
98 |
92 |
$0.00 |
| 3050F |
|
84 |
83 |
$0.00 |
| 3051F |
|
109 |
94 |
$0.00 |
| 3008F |
|
1,860 |
1,824 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
8,048 |
6,772 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
694 |
658 |
$0.00 |
| 1123F |
|
692 |
546 |
$0.00 |
| 3048F |
|
735 |
718 |
$0.00 |
| 3049F |
|
251 |
248 |
$0.00 |
| 3044F |
|
929 |
826 |
$0.00 |
| G8756 |
No documentation of blood pressure measurement, reason not given |
151 |
143 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,816 |
1,565 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
165 |
145 |
$0.00 |
| 3052F |
|
59 |
52 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
15 |
15 |
$0.00 |
| 1111F |
|
70 |
63 |
$0.00 |
| 3061F |
|
26 |
26 |
$0.00 |
| G8430 |
Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) |
39 |
36 |
$0.00 |